Tendee LogoChatBlog
Public Tender Opportunity

Spain – Pharmaceutical products – Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca.

Published on October 7, 2025

Tender Description

Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca. Vigencia del 1 de septiembre de 2025 al 31 de agosto de 2026 o 12 meses desde su formalización.

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.